top of page


InnPROGRESS platform: Gustave Roussy's expertise in clinical trial design
On March 10, 2026, the Ecosystem Breakfast was held on the theme “InnPROGRESS platform: Gustave Roussy's expertise in clinical trial design.” The replay is now available. With: Prof. Benjamin Besse: Professor Benjamin Besse is Director of Clinical Research at Gustave Roussy and Professor of Medical Oncology at Paris-Saclay University. As a medical oncologist, his research focuses on the application of personalized therapeutic strategies based on molecular abnormalities, circ
Mar 11


PSCC Innovation Forum 2026 replays are available!
Relive the Innovation Forum 2026! Find the program at this link. Replays of the program: Welcome address Eric Vivier, PSCC: #1: Progress in Oncologic Surgery Olaf Mercier , Marie Lannelongue Hospital, France. Personalized surgery for lung cancer: #2: Pushing Boundaries in Cancer Treatment Norbert Pardi, Pennsylvania University, US Lipid nanoparticles for mRNA vaccine delivery Antonin de Fougerolles, Etherna, US Optimizing mRNA and LNP for better vaccines and therapeutics i
Mar 3


Alternative Species in Regulatory Toxicology: How to Reduce Your Budget While Preserving Scientific Robustness
On February 17, 2026, the Ecosystem Breakfast took place on the theme "Alternative Species in Regulatory Toxicology: How to Reduce Your Budget While Preserving Scientific Robustness " ; the replay is now available. With : Alexandre Bidaut Head of Alliance Management, ERBC Group Trained as a veterinary pathologist, Alexandre has been coordinating regulatory and non-regulatory preclinical studies for over 20 years within pharmaceutical companies and contract research organi
Feb 17


Reinventing liquid biopsy: towards integrative and personalized medicine
On January 27, 2026, the Ecosystem Breakfast took place on the theme "Reinventing liquid biopsy: towards integrative and personalized medicine " ; the replay is now available. With : Aline Cerf, SmartCatch Access the replay
Jan 28


Deeptech in Glioblastoma
On January 22, 2026, the PSCC and Brain&Mind jointly brought together, at The Hive building on Campus Grand Parc (Villejuif), a broad range of stakeholders involved in innovation in glioblastoma — clinicians, researchers, biotech, medtech and pharmaceutical companies, patients and patient representatives, as well as institutional stakeholders. The objective of this event was to take stock of the latest advances in glioblastoma, to discuss future perspectives from technologica
Jan 22


What uses are there for ARCAD databases?
On January 13, 2026, the Ecosystem Breakfast took place on the theme " What uses are there for ARCAD databases?" , the replay is now available With : Ségolène de Retz is Chief Executive Officer of the Fondation ARCAD . Jean-Baptiste Bachet , MD, PhD, is a digestive oncologist specialized in colorectal and pancreatic cancers. He is involved in numerous clinical and translational research studies and is a member of GERCOR (Groupe d'Étude et de Recherche Clinique en
Jan 13


Detection of Minimal Residual Disease (MRD): A Highly Sensitive Tool for Monitoring Cancer Patients
The Ecosystem Breakfast took place on December 16, 2025, moderated by Céline Capéra , Head of Sales, IntegraGen, and Charles Marcaillou , Head of R&D, IntegraGen. and Séverine Matin-Lannerée , PhD, Head of Quality, IntegraGen The replay of the presentation on the topic " Detection of Minimal Residual Disease (MRD): A Highly Sensitive Tool for Monitoring Cancer Patients " is now available . Access the replay
Dec 17, 2025
Cluster News
bottom of page